These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 175797)

  • 1. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets.
    Malmsten C; Granström E; Samuelsson B
    Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797
    [No Abstract]   [Full Text] [Related]  

  • 2. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of prostaglandin endoperoxide formation in the elevation of cyclic GMP levels during platelet aggregation.
    Glass DB; Gerrard JM; Townsend D; Carr DW; White JG; Goldberg ND
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):37-44. PubMed ID: 191476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of prostaglandin G2 on platelet ultrastructure and platelet secretion.
    Gerrard JM; Townsend D; Stoddard S; Witkop CJ; White JG
    Am J Pathol; 1977 Jan; 86(1):99-116. PubMed ID: 188341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
    Burns GB; Dodge JA
    Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP and platelet prostaglandin synthesis.
    Gerrard JM; Peller JD; Krick TP; White JG
    Prostaglandins; 1977 Jul; 14(1):39-50. PubMed ID: 197570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet prostaglandin production and its implications.
    Smith JB; Ingerman CM; Silver MJ
    Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency.
    Malmsten C; Hamberg M; Svensson J; Samuelsson B
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1446-50. PubMed ID: 1055417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function.
    Claesson HE; Malmsten C
    Eur J Biochem; 1977 Jun; 76(1):277-84. PubMed ID: 195812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog.
    Johnson GJ; Rao GH; Leis LA; White JG
    Blood; 1980 May; 55(5):722-9. PubMed ID: 6244866
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet accumulation on collagen: drugs which inhibit arachidonic acid metabolism and affect intracellular cyclic AMP levels.
    Adams GA; Feuerstein IA
    Thromb Haemost; 1984 Aug; 52(1):45-9. PubMed ID: 6093281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
    [No Abstract]   [Full Text] [Related]  

  • 16. Roles of cyclic nucleotides in platelet function.
    Haslam RJ
    Ciba Found Symp; 1975; 35():121-51. PubMed ID: 179765
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclic AMP induces synthesis of prostaglandin E1 in platelets.
    Dayal V; Colman RW; Prakash O; Bose AK; Sinha AK
    Biochim Biophys Acta; 1983 Sep; 759(3):129-36. PubMed ID: 6309248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present status and prospects of platelet inhibitors].
    Yasunaga K
    Rinsho Ketsueki; 1976 Jun; 17(6):590-9. PubMed ID: 184313
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets.
    Best LC; McGuire MB; Martin TJ; Preston FE; Russell RG
    Biochim Biophys Acta; 1979 Mar; 583(3):344-51. PubMed ID: 221045
    [No Abstract]   [Full Text] [Related]  

  • 20. 15-Hydroperoxyeicosatetraenoic acid inhibits human platelet aggregation.
    Vericel E; Lagarde M
    Lipids; 1980 Jun; 15(6):472-4. PubMed ID: 7401944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.